Yuan Gao

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Cardiovascular Disease

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)